Celescreen Overview

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Angel

  • Latest Deal Amount
  • $35.7K

  • Investors
  • 1

Celescreen General Information

Description

Developer of alternative toxicology testing methods designed to measure the toxicity of foreign chemical substances. The company uses C. elegans worms to test the toxicity levels of consumer products in the fields of pharmaceuticals, cosmetics, and food products, enabling physicians to evaluate systemic toxicity, nephrotoxicity, and teratogenicity, while avoiding vertebrate testing.

Contact Information

Website
www.celescreen.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 2 Rue Ambroise Paré
  • 75010 Paris
  • France
+33 06
Primary Industry
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 2 Rue Ambroise Paré
  • 75010 Paris
  • France
+33 06

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Celescreen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Angel (individual) 20-Aug-2019 $35.7K Completed Product Development
2. Angel (individual) 13-Apr-2017 Completed Product Development
1. Accelerator/Incubator 11-Sep-2014 Completed Product Development
To view Celescreen’s complete valuation and funding history, request access »

Celescreen Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
Ordinary 16,000 $1.114790 $2.68 $2.68 1x $2.68 29.09%
To view Celescreen’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Celescreen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Celescreen Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Agoranov Accelerator/Incubator
To view Celescreen’s complete investors history, request access »

Ready to get started?

Request a free trial

Celescreen FAQs

  • Where is Celescreen headquartered?

    Celescreen is headquartered in Paris, France.

  • What is the size of Celescreen?

    Celescreen has 2 total employees.

  • What industry is Celescreen in?

    Celescreen’s primary industry is Biotechnology.

  • Is Celescreen a private or public company?

    Celescreen is a Private company.

  • What is the current valuation of Celescreen?

    The current valuation of Celescreen is .

  • What is Celescreen’s current revenue?

    The current revenue for Celescreen is .

  • How much funding has Celescreen raised over time?

    Celescreen has raised $98.2K.

  • Who are Celescreen’s investors?

    Agoranov has invested in Celescreen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »